| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 22.94 | 59.89 | 34.4 | 68.24 |
Op profit growth | 26.36 | 33.52 | 56.54 | 94.46 |
EBIT growth | 16.83 | 43.16 | 55.63 | 101.24 |
Net profit growth | 12.67 | 48.49 | 51.43 | 108.92 |
Profitability ratios (%) | ||||
OPM | 30.96 | 30.12 | 36.07 | 30.97 |
EBIT margin | 29.7 | 31.25 | 34.9 | 30.14 |
Net profit margin | 22.82 | 24.9 | 26.82 | 23.8 |
RoCE | 27.89 | 38.43 | 59.68 | 62.64 |
RoNW | 5.67 | 8.19 | 12.29 | 13.54 |
RoA | 5.35 | 7.65 | 11.46 | 12.36 |
Per share ratios (₹) | ||||
EPS | 33.24 | 28.43 | 19.13 | 12.64 |
Dividend per share | 3 | 2.5 | 2 | 1.5 |
Cash EPS | 27.14 | 24.24 | 16.63 | 10.89 |
Book value per share | 156.76 | 125.31 | 48.12 | 29.74 |
Valuation ratios | ||||
P/E | 12.15 | 9.93 | 29.95 | 30.7 |
P/CEPS | 14.89 | 11.64 | 34.43 | 35.63 |
P/B | 3.15 | 2.44 | 11.9 | 13.04 |
EV/EBIDTA | 7.48 | 6.47 | 20.5 | 21.14 |
Payout (%) | ||||
Dividend payout | 0 | 7.38 | 10.44 | 11.85 |
Tax payout | -19.82 | -20.18 | -23.22 | -21.03 |
Liquidity ratios | ||||
Debtor days | 87.41 | 75.02 | 53.71 | 18.61 |
Inventory days | 71.74 | 56.38 | 17.15 | 18.67 |
Creditor days | -41.02 | -53.24 | -102.19 | -96.33 |
Leverage ratios | ||||
Interest coverage | -198.29 | -843.86 | -3,079.07 | -949.6 |
Net debt / equity | -0.35 | -0.19 | -0.21 | -0.41 |
Net debt / op. profit | -1.27 | -0.71 | -0.4 | -0.74 |
Cost breakup (₹) | ||||
Material costs | -44.44 | -47.86 | -44.12 | -46.04 |
Employee costs | -9.66 | -7.84 | -7.25 | -7.67 |
Other costs | -14.92 | -14.15 | -12.55 | -15.3 |
The drug is the generic alternative of the Vitamin K1 Injection produced by Hospira Inc and is indicated in the treatment of Vitamin K deficiency-related coagulation disorders.
Here are some of the stocks that may see significant price movement today: ICICI Prudential, Caplin Point, Ashoka Buildcon, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
